Palo Alto Investors LP Long-Term Concentrated

CIK: 0001306923 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value ($000): $2,502,471 (100.0% shares, 0.0% debt)

Holdings (36)

ABIOMED INC 14.6%
Value ($000) $364,181 Shares 890,309 Est. Cost $32.04 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 9.6%
Value ($000) $240,156 Shares 2,549,431 Est. Cost $79.79 Unrealized +9.8%
CLOVIS ONCOLOGY INC 9.0%
Value ($000) $226,168 Shares 4,974,007 Est. Cost $52.39 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 7.3%
Value ($000) $183,895 Shares 1,625,234 Est. Cost $88.73 Unrealized +23.9%
INSM INSMED INC 6.8%
Value ($000) $171,145 Shares 7,236,583 Est. Cost $16.77 Unrealized +53.5%
ALEXION PHARMACEUTICALS INC 5.9%
Value ($000) $147,295 Shares 1,186,427 Est. Cost $121.06 Unrealized
SAGE THERAPEUTICS INC 5.2%
Value ($000) $130,317 Shares 832,536 Est. Cost $48.02 Unrealized
IMMUNOMEDICS INC 4.5%
Value ($000) $113,696 Shares 4,803,364 Est. Cost $11.54 Unrealized
STAA STAAR SURGICAL CO 4.4%
Value ($000) $109,169 Shares 3,521,565 Est. Cost $8.00 Unrealized +192.4%
FOLD AMICUS THERAPEUTICS INC 3.9%
Value ($000) $96,350 Shares 6,168,347 Est. Cost $6.44 Unrealized +134.7%
EPIZYME INC 3.7%
Value ($000) $93,578 Shares 6,906,158 Est. Cost $15.12 Unrealized
KARYOPHARM THERAPEUTICS INC 3.2%
Value ($000) $79,230 Shares 4,663,324 Est. Cost $18.85 Unrealized
VNDA VANDA PHARMACEUTICALS INC 3.2%
Value ($000) $79,166 Shares 4,155,670 Est. Cost $8.70 Unrealized +92.1%
WRIGHT MED GROUP N V 2.9%
Value ($000) $71,587 Shares 2,757,587 Est. Cost $23.42 Unrealized
AMAG PHARMACEUTICALS INC 2.6%
Value ($000) $65,146 Shares 3,340,806 Est. Cost $29.37 Unrealized
ALGN ALIGN TECHNOLOGY INC 2.5%
Value ($000) $63,161 Shares 184,607 Est. Cost $98.66 Unrealized +202.4%
MOMENTA PHARMACEUTICALS INC 1.5%
Value ($000) $37,496 Shares 1,833,532 Est. Cost $14.12 Unrealized
AIMMUNE THERAPEUTICS INC 1.5%
Value ($000) $37,155 Shares 1,381,759 Est. Cost $23.79 Unrealized
SHIRE PLC 1.3%
Value ($000) $32,275 Shares 191,200 Est. Cost $197.13 Unrealized
CELGENE CORP 1.3%
Value ($000) $31,358 Shares 394,840 Est. Cost $95.51 Unrealized
ALDER BIOPHARMACEUTICALS INC 1.2%
Value ($000) $29,279 Shares 1,853,101 Est. Cost $11.48 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 1.0%
Value ($000) $25,207 Shares 1,650,780 Est. Cost $29.82 Unrealized -40.2%
EXAS EXACT SCIENCES CORP 0.7%
Value ($000) $18,733 Shares 313,320 Est. Cost $13.61 Unrealized +295.3%
PRTA PROTHENA CORP PLC 0.6%
Value ($000) $16,086 Shares 1,103,325 Est. Cost $32.98 Unrealized -40.1%
GILD GILEAD SCIENCES INC 0.5%
Value ($000) $12,461 Shares 175,900 Est. Cost $62.02 Unrealized -15.0%
RIGEL PHARMACEUTICALS INC 0.4%
Value ($000) $11,224 Shares 3,966,087 Est. Cost $3.40 Unrealized
DICERNA PHARMACEUTICALS INC 0.2%
Value ($000) $6,136 Shares 500,913 Est. Cost $5.39 Unrealized
ALIMERA SCIENCES INC 0.1%
Value ($000) $2,948 Shares 3,013,793 Est. Cost $4.88 Unrealized
SUNESIS PHARMACEUTICALS INC 0.1%
Value ($000) $2,464 Shares 1,162,473 Est. Cost $4.37 Unrealized
ZOGENIX INC 0.1%
Value ($000) $1,304 Shares 29,500 Est. Cost $13.36 Unrealized
CYTK CYTOKINETICS INC 0.0%
Value ($000) $1,027 Shares 123,686 Est. Cost $6.71 Unrealized +24.0%
IDERA PHARMACEUTICALS INC 0.0%
Value ($000) $814 Shares 616,355 Est. Cost $3.70 Unrealized
HISTOGENICS CORP 0.0%
Value ($000) $757 Shares 302,922 Est. Cost $11.00 Unrealized
SOPHIRIS BIO INC 0.0%
Value ($000) $694 Shares 247,000 Est. Cost $2.60 Unrealized
TREVENA INC 0.0%
Value ($000) $491 Shares 341,300 Est. Cost $2.30 Unrealized
MELINTA THERAPEUTICS INC 0.0%
Value ($000) $322 Shares 50,689 Est. Cost $15.80 Unrealized